IBIO, INC. Inventory
IBIO, INC. (IBIO) had Inventory of $0 as of 2024-06-30, per its 10-K/A filed 2024-09-24.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2024-09-24
- 2024-06-30: Inventory, Net $0.00.
- 2024-03-31: Inventory, Net $0.00.
- 2023-12-31: Inventory, Net $0.00.
- 2023-09-30: Inventory, Net $0.00.
| Period end | Inventory, Net |
|---|---|
| 2024-06-30 | $0.00 10-K/A · filed 2024-09-24 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-09 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-K/A · filed 2024-09-24 |
| 2022-06-30 | $3.90M 10-K · filed 2023-09-27 |
| 2022-03-31 | $3.28M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.99M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $587.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $27.00K 10-K · filed 2022-10-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |